Palmer, G., Burger, D., Mezin, F., Magne, D., Gabay, C., Dayer, J., & Guerne, P. (2004). The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes. BioMed Central.
Citação norma ChicagoPalmer, Gaby, Danielle Burger, Françoise Mezin, David Magne, Cem Gabay, Jean-Michel Dayer, and Pierre-André Guerne. The Active Metabolite of Leflunomide, A77 1726, Increases the Production of IL-1 Receptor Antagonist in Human Synovial Fibroblasts and Articular Chondrocytes. BioMed Central, 2004.
Citação norma MLAPalmer, Gaby, et al. The Active Metabolite of Leflunomide, A77 1726, Increases the Production of IL-1 Receptor Antagonist in Human Synovial Fibroblasts and Articular Chondrocytes. BioMed Central, 2004.